An acknowledged problem in public health surveys is that those who take part are generally more health conscious and healthier than those who do not. If this is also true of colon cancer screening, it means, at worst, that the people at greatest risk of developing the disease are not being screened, even though they would benefit most from the procedure.
A new study from Karolinska Institutet has confirmed these fears. Nine years ago, a team of researchers invited 2,000 people between the ages of 59 and 61 to take part in a colon cancer screening programme. Thirty-nine per cent of them accepted, but 61 per cent chose not to. A follow-up of these two groups has now shown that a larger percentage of the non-participants have since developed colon cancer or died, either from colon cancer or other diseases, compared with the participants.
“We do not think that the difference in incidences of cancer and death between the two groups is due to any effect the screening might have had, but believe it was down to the selection of people who took part,” says Johannes Blom, one of the researchers behind the study. “What we have here is the self-selection of more health conscious and healthier people , who perhaps don’t benefit as much from taking part.”
The team believes that those who opted out of the programme have less healthy lifestyles. This is supported by the findings that more of the non-participants have developed other forms of smoking-related cancer and that they run more than double the risk of dying from cardiovascular disease.
“If higher-risk people choose not to take part, public screening programmes will become very cost inefficient,” says Dr Blom. “One of the greatest challenges is therefore to encourage participation, so that the less motivated are also screened.”
On 1 January, the Stockholm County Council became the first health authority in Sweden to launch a screening programme for colon cancer.
Katarina Sternudd | alfa
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy